Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Sodium valproate
- Therapeutic area
- CNS & mental health
- Drug class
- Antiepileptics
- ATC
- N03
- Strength
- 250 mg/5 mL
- Dosage form
- Syrup
- Pack
- 60 ml
- Registration no.
- 066655
- Price record verified
- 2026-08-09
- Latest DRAP source check
- 2026-11-11 02:59
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →What Vazipro (Sodium valproate) is used for
Sodium valproate is an anti-epileptic medicine. It works by calming down electrical activity in the brain, which helps to prevent fits (seizures). It is a prescription-only medicine. In the UK, anyone under 55 must have it prescribed by a specialist, and a second specialist must agree that there is no other suitable treatment. Valproate can seriously harm an unborn baby, so there are strict rules about its use in anyone who could become pregnant.
- Epilepsy (fits or seizures) in adults and children
- Bipolar disorder in adults
- Sometimes, helping to prevent migraine attacks in adults, usually only after other preventive medicines have not suited (never in pregnancy or in anyone who could become pregnant)
Get medical help straight away if
- Call an ambulance or go to the emergency department if you have thoughts of harming yourself or ending your life. Family members and carers should also watch for changes in mood or behaviour.
- Call an ambulance for signs of a severe allergic reaction: sudden swelling of the lips, mouth, throat or tongue, very fast or difficult breathing, wheezing or choking, a tight throat, blue, grey or pale skin or lips, sudden severe confusion or drowsiness, or fainting. A child may become limp or floppy.
- Get urgent help for a rash that is swollen, raised, blistered or peeling.
- Contact a doctor straight away for yellow skin or eyes or dark urine. These can be signs of liver damage, which is rare but can be life-threatening.
Side effects, warnings and interactions for Sodium valproate
Prepared from the sources listed by the MedInfoBase team. General information, not medical advice: it gives no doses. Your doctor or pharmacist decides the medicine and dose for you.
Our condition guides that mention Sodium valproate
From our condition guides, written from WHO, NICE and other opened sources. Your doctor decides if Sodium valproate is right for you and the dose.
About Vazipro 250 mg/5 mL syrup
Vazipro 250 mg/5 mL syrup contains Sodium valproate 250 mg/5 mL. It is registered with DRAP by Glitz Pharma (registration no. 066655). Its official price is PKR 110.02 for a pack of 60 ml. The price changed from PKR 104.84 to PKR 110.02 on 28 September 2026. Vazipro is also available as 500 mg tablet. 9 other brands of Sodium valproate 250 mg/5 mL (syrup) are registered in Pakistan. Compare all brands and prices →
Other strengths of Vazipro
All 9 other brands of Sodium valproate 250 mg/5 mL syrup in Pakistan
These 9 brands are alternatives (substitutes) to Vazipro: each contains Sodium valproate 250 mg/5 mL syrup. Ask your doctor or pharmacist before you switch brands.
Sorted by price per mL, lowest first. The lowest is Epiwin (CRYSTOLITE PHARMACEUTICALS) at PKR 1.62 per mL; the highest is EPIVAL at PKR 2.25. All prices are official DRAP prices.
| Brand | Company | Pack | Official price | Per unit |
|---|---|---|---|---|
| Epiwin | CRYSTOLITE PHARMACEUTICALS | 60ml | PKR 97.08 | PKR 1.62 / mL |
| Depilap | Neutro Pharma (Pvt.) Ltd | 60ml | PKR 99.73 | PKR 1.66 / mL |
| Wapival | Winthrox Laboratories Pvt. Ltd | 60ml | PKR 100.87 | PKR 1.68 / mL |
| Divanza | Hiranis Pharmaceuticals Pvt. Ltd | 60ml | PKR 106.64 | PKR 1.78 / mL |
| DAPAKAN | Platinum Pharmaceuticals | 300ml | PKR 539.11 | PKR 1.80 / mL |
| Leptil | Don Valley | 120ml | PKR 220.04 | PKR 1.83 / mL |
| Dipodium | Amarant Pharmaceuticals Private Limited | 60mL | PKR 110.02 | PKR 1.83 / mL |
| W-val | Welmed Pharmaceutical Industries (Pvt) Ltd | 60ml | PKR 110.02 | PKR 1.83 / mL |
| EPIVAL | Abbott Laboratories (Pakistan) Limited | 60ml | PKR 134.81 | PKR 2.25 / mL |
Where to buy
MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for Vazipro, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.
- Registration holder
- Glitz Pharma, Islamabad
- DRAP registration
- 066655
- Phone
- +92 51 5552613; +92 51 4491310
- info@glitzpharma.net
- Website
- https://glitzpharma.net/
- Contact page
- Company contact page
Contact details as published by the company, last checked on 16 August 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.
Official price over time
PKR 104.84 to 110.02 (+4.9%) between 4 Sep 2025 and 28 Sep 2026 · 2 official price records · pack 60 ml
Step chart: a notified price holds until DRAP notifies the next one. Hover or tap a point for its date and change.
Cite this price history
MedInfoBase. Vazipro 250 mg/5 mL, 60 ml: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/vazipro-250-mg-5-ml-066655-60-ml-glitz-pharma/ (accessed 11 November 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 110.02 | 2026-09-28 | 2026-09-29 | DRAP PharmaPrice Index (refreshed from snapshot #91) | Current |
| PKR 104.84 | 2025-09-04 | 2026-08-09 | DRAP PharmaPrice Index | Historical |
Cite this record
Medicine record · DRAP registration 066655Price and registration data on this page were observed on 29 September 2026. Records change over time, so please cite the observation date alongside the access date.